| Autor: |
Thorne JC; Rheumatologist, Chief Division of Rheumatology, Medical Director, The Arthritis Program, Southlake Regional Health Centre, Newmarket;, Nadarajah T; Rheumatology Fellow, University of Toronto, Adult Rheumatology program; thanu.nadarajah@gmail.com., Moretti M; Assistant Director, Motherisk Program/Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children;, Ito S; Division Head, Clinical Pharmacology and Toxicology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada. |
